HERE FOR 20 YEARS FOR PEOPLE WITH AN INTEREST IN MULTIPLE SCLEROSIS Skip to content

(Abst.) Dissemination in time as a requirement for dx of MS: Time for a change?

558 Views 0 Replies

0 Members and 2 Guests are viewing this topic.

#1

This MS researcher is proposing giving less attention to dissemination in time as a requirement when diagnosing MS if I read this abstract correctly. Since there is considerable evidence now that zapping MS early with one of the MS therapies--and even with one of the more powerful therapies at first, it looks as if putting less emphasis on dissemination in time in the diagnosis process will make it easier to get more people on an MS drug sooner rather than later.

From PubMed (February 28, 2024)--"Dissemination in time as a requirement for diagnosis of multiple sclerosis:  Time for a change?"


The requirement to demonstrate dissemination in time (DIT) in order to diagnose multiple sclerosis (MS) has been enshrined in the literature since earliest efforts to establish diagnostic critera. ...
PubMed · pubmed.ncbi.nlm.nih.gov
MS Speaks--online for 20 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week)  12/16/20 - 3/16/24.